Found: 80
Select item for more details and to access through your institution.
Issues and progress with protein kinase inhibitors for cancer treatment.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 4, p. 296, doi. 10.1038/nrd1066
- By:
- Publication type:
- Article
Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 22, p. 1736
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 10, p. 875
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 10, p. 874
- By:
- Publication type:
- Article
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2.
- Published in:
- Pharmaceuticals (14248247), 2016, v. 9, n. 1, p. 4, doi. 10.3390/ph9010004
- By:
- Publication type:
- Article
A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.
- Published in:
- BMC Structural Biology, 2016, v. 16, p. 1, doi. 10.1186/s12900-016-0052-x
- By:
- Publication type:
- Article
T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Aurora kinases dawn as cancer drug targets.
- Published in:
- Nature Medicine, 2004, v. 10, n. 3, p. 234, doi. 10.1038/nm0304-234
- By:
- Publication type:
- Article
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 881, doi. 10.1111/bjh.16261
- By:
- Publication type:
- Article
A gene expression database for the molecular pharmacology of cancer.
- Published in:
- Nature Genetics, 2000, v. 24, n. 3, p. 236, doi. 10.1038/73439
- By:
- Publication type:
- Article
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 74, doi. 10.1177/1078155219838316
- By:
- Publication type:
- Article
Identification of small molecule inhibitors of anthrax lethal factor.
- Published in:
- Nature Structural & Molecular Biology, 2004, v. 11, n. 1, p. 67, doi. 10.1038/nsmb711
- By:
- Publication type:
- Article
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8
- By:
- Publication type:
- Article
First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 440, doi. 10.1007/s10637-015-0211-0
- By:
- Publication type:
- Article
Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
- Published in:
- World Journal of Surgical Oncology, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12957-018-1505-4
- By:
- Publication type:
- Article
Preclinical Modeling of Combination Treatments: Fantasy or Requirement?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1059, n. 1, p. 61, doi. 10.1196/annals.1339.024
- By:
- Publication type:
- Article
Inhibition of CDKs as a Therapeutic Modality.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 910, n. 1, p. 207, doi. 10.1111/j.1749-6632.2000.tb06710.x
- By:
- Publication type:
- Article
Strategy and planning for chemopreventive drug development: Clinical development plans.
- Published in:
- Journal of Cellular Biochemistry, 1994, v. 56, p. 55, doi. 10.1002/jcb.240560906
- By:
- Publication type:
- Article
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
- Published in:
- Nature, 1985, v. 318, n. 6041, p. 69, doi. 10.1038/318069a0
- By:
- Publication type:
- Article
Respecting Cancer Drug Transportability: A Basis for Successful Lead Selection.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Versipelostatin: Unfolding an Unsweetened Death.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 17, p. 1266, doi. 10.1093/jnci/djh276
- By:
- Publication type:
- Article
Dragons 'Round the Fleece Again.
- Published in:
- 2000
- By:
- Publication type:
- Editorial
Preclinical and clinical development of cyclin-dependent kinase modulators.
- Published in:
- 2000
- By:
- Publication type:
- journal article
A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: a promising path for progress emerges.
- Published in:
- 1999
- By:
- Publication type:
- commentary
Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
- Published in:
- Oncogene, 2005, v. 24, n. 23, p. 3697, doi. 10.1038/sj.onc.1208499
- By:
- Publication type:
- Article
The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x<sub>L</sub> protein.
- Published in:
- Oncogene, 2005, v. 24, n. 1, p. 148, doi. 10.1038/sj.onc.1207842
- By:
- Publication type:
- Article
Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process.
- Published in:
- Oncogene, 2004, v. 23, n. 7, p. 1364, doi. 10.1038/sj.onc.1207248
- By:
- Publication type:
- Article
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Prolactin-producing pituitary carcinoma with pulmonary metastases.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A protein expression database for the molecular pharmacology of cancer.
- Published in:
- Electrophoresis, 1997, v. 18, n. 3/4, p. 647, doi. 10.1002/elps.1150180351
- By:
- Publication type:
- Article
Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 160, doi. 10.1007/s10637-013-9988-x
- By:
- Publication type:
- Article
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1217, doi. 10.1007/s10637-013-9937-8
- By:
- Publication type:
- Article
Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 5, p. 367, doi. 10.1007/s10637-005-5707-6
- By:
- Publication type:
- Article
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma.
- Published in:
- Biomedical Chromatography, 2002, v. 16, n. 6, p. 379, doi. 10.1002/bmc.166
- By:
- Publication type:
- Article
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva.
- Published in:
- Biomedical Chromatography, 2000, v. 14, n. 5, p. 338, doi. 10.1002/1099-0801(200008)14:5<338::AID-BMC993>3.0.CO;2-6
- By:
- Publication type:
- Article
A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer.
- Published in:
- Urologia Internationalis, 1999, v. 63, n. 2, p. 120, doi. 10.1159/000030430
- By:
- Publication type:
- Article
Reviews and notes: Oncology.
- Published in:
- 1995
- By:
- Publication type:
- Book Review
Schistocytes, Echinocytes, Iron Deficiency Anemia, and Thrombocytopenia -- Hematologic Manifestations of Splenic Angiosarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Schistocytes, Echinocytes, Iron Deficiency Anemia, and Thrombocytopenia -- Hematologic Manifestations of Splenic Angiosarcoma.
- Published in:
- Archives of Iranian Medicine (AIM), 2013, v. 16, n. 10, p. 602
- By:
- Publication type:
- Article
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cytotoxic drugs: past, present and future.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autophagy modulation: a target for cancer treatment development.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 439, doi. 10.1007/s00280-014-2637-z
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 955, doi. 10.1007/s00280-014-2569-7
- By:
- Publication type:
- Article
Asparaginase in the treatment of non-ALL hematologic malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 875, doi. 10.1007/s00280-014-2402-3
- By:
- Publication type:
- Article
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 3, p. 539, doi. 10.1007/s00280-014-2380-5
- By:
- Publication type:
- Article
A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 4, p. 861, doi. 10.1007/s00280-013-2267-x
- By:
- Publication type:
- Article